Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12077539 Imidazole and triazole KRAS inhibitors

Patent 12077539 was granted and assigned to Incyte on September, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Wenqing Yao0

Chao Qi0

Xiaozhao Wang0

Date of Patent

September 3, 2024

0

Patent Application Number

177009230

Date Filed

March 22, 2022

0

Patent Citations

US Patent 8207187 Use of pyrroloquinoline compounds to kill clinically latent microorganisms

0

US Patent 8513250 Imidazolo-heteroaryl derivatives with antibacterial properties

0

US Patent 8557984 Imidazo [4, 5-C] quinoline derivatives as bromodomain inhibitors

0

US Patent 8563565 Pyrazoloquinoline derivatives

0

US Patent 8637670 Imidazo [4,5-C]quinoline derivatives and their use in the treatment of tumors and/or inflammation

0

US Patent 8658666 Substituted imidazoquinolines and imidazonaphthyridines

0

US Patent 8846710 Method of preferentially inducing the biosynthesis of interferon

0

US Patent 8895581 1

0

...

Patent Primary Examiner

Charanjit Aulakh

0

CPC Code

0

0

0

0

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12077539 Imidazole and triazole KRAS inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool